This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by FELDMAN, E. B. Articles by WALLACE, S. L. Search for Related Content PubMed PubMed Citation Articles by FELDMAN, E. B. Articles by WALLACE, S. L.

(Circulation. 1964;29:508.)
© 1964 American Heart Association, Inc.

---

Hypertriglyceridemia in Gout

ELAINE B. FELDMAN M.D.¹ STANLEY L. WALLACE M.D.¹

¹ From the Department of Medicine, State University of New York, Downstate Medical Center, Kings County, Hospital, and Brooklyn Jewish Hospital, Brooklyn, New York.

Serum triglyceride levels were significantly higher in 34 patients with gout (42 mg. per 100 ml.) in comparison to the levels in 28 healthy men over 35 years of age (100 mg. per 100 ml.). There was no significant predictive relation between levels of serum uric acid and triglycerides in either group. No significant difference in serum cholesterol levels nor lipoprotein profile was apparent between the two groups. The patients with gout had been selected to exclude any manifestations of atherosclerosis or other disease known to be associated with abnormalities in circulating lipids. The results provide support for possible linkage of genetic factors influencing uric acid and triglyceride metabolism. The presence of hypertriglyceridemia in gout may be correlated with the increased incidence of arteriosclerosis.

This article has been cited by other articles:

				M. D. Feher, A. L. Hepburn, M. B. Hogarth, S. G. Ball, and S. A. Kaye Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout Rheumatology, February 1, 2003; 42(2): 321 - 325. [Abstract] [Full Text] [PDF]

				A L HEPBURN, S A KAYE, and M D FEHER Fenofibrate: a new treatment for hyperuricaemia and gout? Ann Rheum Dis, October 1, 2001; 60(10): 984a - 986. [Full Text] [PDF]

				H Oya, N Nagaya, T Satoh, F Sakamaki, S Kyotani, M Fujita, N Nakanishi, and K Miyatake Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome Heart, July 1, 2000; 84(1): 53 - 58. [Abstract] [Full Text] [PDF]

				N. NAGAYA, M. UEMATSU, T. SATOH, S. KYOTANI, F. SAKAMAKI, N. NAKANISHI, M. YAMAGISHI, T. KUNIEDA, and K. MIYATAKE Serum Uric Acid Levels Correlate with the Severity and the Mortality of Primary Pulmonary Hypertension Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 487 - 492. [Abstract] [Full Text]

				B. EMMERSON Hyperlipidaemia in hyperuricaemia and gout Ann Rheum Dis, September 1, 1998; 57(9): 509 - 510. [Full Text]

				S. G. Chrysant, G. K. Neller, B. Dillard, and E. D. Frohlich Effects of Diuretics On Lipid Metabolism in Patients With Essential Hypertension Angiology, December 1, 1976; 27(12): 707 - 711. [PDF]